Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tripar Multivision Plus Tbk. (RAAM) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance

Tripar Multivision Plus Tbk.Trade
Charlie Hospital Semarang Tbk.Trade

Price performance (Past 24H)

Key statistics

Tripar Multivision Plus Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Tripar Multivision Plus Tbk. trades at Rp186 (market cap 1.28T, 256.2K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp312 (market cap 821.5B, 25.59M 24h volume). The key difference: Tripar Multivision Plus Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.59M versus 256.2K). Which is the better fit depends on your goals.

RAAMRSCH
Market Cap
1.28T821.5B
Volume
256.2K25.59M
Lot
2.56K255.95K
Turnover
47.62M7.95B
Average Price
185.86310.77
Value
47.62M7.95B
Indicative Equilibrium Price
186312
Indicative Equilibrium Volume
1010

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RAAM
View details
RSCH
View details

About Tripar Multivision Plus Tbk.

PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.

Read more on RAAM

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH